Tumor biology remains the main determinant of prognosis in retroperitoneal sarcomas: a 14‐year single‐center experience
Deanna Ng(Mount Sinai Hospital), Melissa Ching Ching Teo(National Cancer Centre Singapore), Grace Hwei Ching Tan(National Cancer Centre Singapore), Soo Khee Chee(National Cancer Centre Singapore), Richard Quek(National Cancer Centre Singapore), Mohamad Farid(National Cancer Centre Singapore), Claramae Shulyn Chia(National Cancer Centre Singapore)
Cited by 5
Related Papers
Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group
|Annals of Surgical Oncology|2021|243
Preoperative Radiotherapy in Patients With Primary Retroperitoneal Sarcoma
|Annals of Surgery|2022|138
Has the Outcome for Patients Who Undergo Resection of Primary Retroperitoneal Sarcoma Changed Over Time? A Study of Time Trends During the Past 15 years
|Annals of Surgical Oncology|2020|56
FAM46C/TENT5C functions as a tumor suppressor through inhibition of Plk4 activity
|Communications Biology|2020|34
Longitudinal prognostication in retroperitoneal sarcoma survivors: Development and external validation of two dynamic nomograms
|European Journal of Cancer|2021|32